Iovance Biotherapeutics Inc (IOVA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.79
• Market Cap: $1.52B
• EPS: $-1.19
• 52-Week High: $4.57
• 52-Week Low: $1.64

Market Sentiment

Iovance Biotherapeutics Inc currently has a Bullish sentiment score of 0.42.

About Iovance Biotherapeutics Inc

Iovance Biotherapeutics, Inc. is a leading clinical-stage biotechnology company located in San Carlos, California, focused on transformative cancer immunotherapy through its innovative tumor-infiltrating lymphocyte (TIL) therapy. This proprietary approach harnesses the power of the patient's immune system to effectively target and combat various malignancies, particularly melanoma and cervical cancer. With an advancing pipeline and a dedication to scientific rigor, Iovance is strategically po...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Iovance Biotherapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IOVA pay dividends?

Iovance Biotherapeutics Inc (IOVA) does not currently pay a regular dividend.

What is IOVA's market cap?

Iovance Biotherapeutics Inc (IOVA) has a market capitalization of $1.52B with a current stock price of $3.79.